Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.99 EUR | +0.25% | -0.99% | +6.10% |
15/04 | Faron Pharmaceuticals reappoints former finance chief on interim basis | AN |
14/02 | Biohit Oyj Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 46
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Diagnostic Tests, Analysis Systems, and Products
100.0
%
| 11 | 100.0 % | 13 | 100.0 % | +19.40% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Europe, Other
43.6
%
| 5 | 41.9 % | 6 | 43.6 % | +24.16% |
Asia
34.9
%
| 5 | 43.2 % | 5 | 34.9 % | -3.51% |
Other Countries
17.4
%
| 1 | 10.2 % | 2 | 17.4 % | +103.03% |
North and South America
2.5
%
| 0 | 2.5 % | 0 | 2.5 % | +18.25% |
Finland
1.6
%
| 0 | 2.1 % | 0 | 1.6 % | -10.21% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jussi Hahtela
CEO | Chief Executive Officer | 51 | 04/21/04 |
Jussi Sorvo
DFI | Director of Finance/CFO | 34 | 01/21/01 |
Panu Hendolin
CTO | Chief Tech/Sci/R&D Officer | 53 | 01/22/01 |
Kalle Härkönen
BRD | Director/Board Member | 56 | 01/20/01 |
Graham Johnson
SAM | Sales & Marketing | - | 22/11 |
General Counsel | 37 | 01/14/01 | |
Ilari Patrakka
PRN | Corporate Officer/Principal | 44 | 01/12/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 56 | 14/23/14 | |
Founder | 81 | 01/88/01 | |
Director/Board Member | 73 | 24/19/24 | |
Kalle Härkönen
BRD | Director/Board Member | 56 | 01/20/01 |
Franco Aiolfi
BRD | Director/Board Member | 77 | 08/13/08 |
Feng Liu
BRD | Director/Board Member | 52 | 16/18/16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 20 | 2,975,500 | 0 | 0 | 42.47 % |
Stock B | 1 | 12,198,093 | 6,444,275 ( 52.83 %) | 0 |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.10% | 32.22M | |
+9.51% | 8.27B | |
-8.87% | 2.86B | |
+5.40% | 2.17B | |
-25.84% | 1.13B | |
-7.36% | 824M | |
-22.21% | 764M | |
-10.95% | 781M | |
-56.76% | 684M | |
-23.48% | 682M |
- Stock Market
- Equities
- BIOBV Stock
- Company Biohit Oyj